US Q2 Consumer Health Earnings Preview: Horizon Brightens Beyond Current Questions, Challenges?

Consumer health product firms’ vistas include challenges of supply chain disruptions lingering from pandemic’s impact as well as potential for marketplace restrictions as additional varieties of the novel coronavirus spread. Clouds also include shifts in consumer spending, increases in costs caused by inflation and foreign exchange headwinds as the value of the US dollar strengthens against other currencies.

The US consumer health products industry could be looking ahead and seeing an improving outlook for growth since the Food and Drug Administration published a long-awaited proposal for facilitating additional OTC drug switches.

Manufacturers and marketers also likely are seeing a brighter marketplace on the horizon after a Perrigo Company PLC business...